S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Nuvion Integrates Ripple USD to Streamline Global Business Payments

Moving money across borders remains a fragmented burden for modern firms trapped in legacy financial systems. Nuvion is now attempting to bypass these traditional hurdles by integrating Ripple USD (RLUSD) into its AI-powered platform, bridging the gap between conventional fiat banking and blockchain-based settlement networks for international enterprises.

The integration allows businesses to shift between traditional banking rails and digital asset networks through a single, unified infrastructure layer. By adopting RLUSD, Nuvion aims to provide companies with faster settlement times and greater liquidity management, effectively reducing reliance on slow correspondent banking systems. The platform now supports seamless movement between fiat currencies and stablecoins, offering an enterprise-grade toolkit that includes embedded payment APIs and global treasury management.

Keisha Clark, Managing Director of Nuvion, stated that the company views the future of finance as increasingly programmable and real-time. By providing access to RLUSD, Nuvion intends to offer firms the flexibility required to scale operations internationally without the usual friction of cross-border value transfer. Lauren Berta, Product Lead at Ripple, added that the move highlights the practical utility of stablecoins in delivering compliant, transparent payment solutions for fintechs and global enterprises.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!